| Catalog Number |
1804250-33 |
| Medical Device Problem Codes |
Difficult to Remove (1528); Failure to Advance (2524)
|
| Health Effect - Clinical Code |
No Consequences Or Impact To Patient (2199)
|
| Date of Event |
12/02/2020
|
|
Type of Reportable Event
|
Malfunction
|
|
Additional Manufacturer Narrative
|
|
The device was not returned for analysis.A review of the lot history record identified no manufacturing nonconformities issued to the reported lot that would have contributed to this event.Additionally, a review of the complaint history did not indicate a lot specific quality issue.The investigation determined the reported difficulties appear to be related to circumstances of the procedure as it is likely that resistance was met with the heavily calcified and 99% stenosed anatomy resulting in the reported failure to advance and the reported difficult to remove.There is no indication of a product quality issue with respect to manufacture, design or labeling.
|
| |
|
Event or Problem Description
|
|
It was reported that the procedure was to treat a de novo lesion located in the mid-left anterior descending coronary artery that was heavily calcified and 99% stenosed.The xience skypoint stent delivery system failed to cross and there was resistance during removal with the anatomy.The procedure was completed with another device.There were no reported adverse patient effects and no clinically significant delay in the procedure.No additional information was provided.
|
| |
|
Additional Manufacturer Narrative
|
|
The xience skypoint is currently not commercially available in the us; however, it is similar to a device sold in the us.
|
| |
|
Search Alerts/Recalls
|